Related Experiment Video
Updated: Jun 16, 2025
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Peptide therapy: new promising therapeutics for acute kidney injury
Herui Hao1, Fengjiao Bao1, Yuru Wang1
1School of Disaster and Emergency Medicine, Tianjin University, No. 92 Weijin Road, Nankai District, Tianjin 300072, China; Faculty of Medicine, Tianjin University, China.
Abstract:
Acute kidney injury (AKI) is a common fatal condition among hospitalized patients. AKI may be induced by a variety of complicating factors such as sepsis, ischemia-reperfusion injury, nephrotoxic substances, and rhabdomyolysis. At present, symptomatic treatment is mainly used, and there are no US Food and Drug Administration (FDA)-approved drugs for the prevention or treatment of AKI. Peptides have become a promising area of research in AKI treatment because of their high efficiency and low toxicity. In this paper, we systematically review the experimental advancements of peptide therapy for AKI, analyze the mechanism of peptide action in different pathological models, discuss the challenges facing peptide therapy, and provide a scientific basis for further clinical research.
Insights
Peptide therapy shows promise for treating acute kidney injury (AKI), a common fatal condition. This review explores peptide mechanisms and challenges, offering a basis for future clinical research on novel AKI treatments.
Area of Science:
- Nephrology
- Biochemistry
- Pharmacology
Background:
- Acute kidney injury (AKI) is a frequent and fatal complication in hospitalized patients.
- Common causes include sepsis, ischemia-reperfusion, nephrotoxins, and rhabdomyolysis.
- Current treatments for AKI are primarily symptomatic, with no FDA-approved drugs for prevention or treatment.
Purpose of the Study:
- To systematically review experimental advancements in peptide therapy for AKI.
- To analyze the mechanisms of peptide action in various AKI pathological models.
- To discuss challenges and provide a scientific basis for clinical research.
Main Methods:
- Systematic literature review of experimental studies on peptide therapy for AKI.
- Analysis of peptide mechanisms across different AKI models.
- Discussion of current challenges and future directions.
Main Results:
- Peptides offer a promising therapeutic strategy for AKI due to their high efficacy and low toxicity.
- Various peptides have demonstrated potential in preclinical AKI models.
- Understanding peptide mechanisms is crucial for optimizing treatment strategies.
Conclusions:
- Peptide therapy represents a promising avenue for AKI treatment, addressing the lack of specific drugs.
- Further research into peptide mechanisms and clinical trials is warranted.
- This review provides a foundation for developing effective peptide-based AKI interventions.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System